Patents by Inventor Nathan D. Ide

Nathan D. Ide has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid forms of a selective CDK4/6 inhibitor
    Patent number: 10723730
    Abstract: This invention relates to the crystalline free base of acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, formula (1) having improved properties, to pharmaceutical compositions and dosage forms comprising the free base, and to methods for making and using such compounds, compositions and dosage forms in the treatment of cell proliferative diseases, such as cancer.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: July 28, 2020
    Assignee: Pfizer Inc.
    Inventors: Brian Patrick Chekal, Nathan D. Ide
  • SOLID FORMS OF A SELECTIVE CDK4/6 INHIBITOR
    Publication number: 20180065964
    Abstract: This invention relates to the crystalline free base of acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, formula (1) having improved properties, to pharmaceutical compositions and dosage forms comprising the free base, and to methods for making and using such compounds, compositions and dosage forms in the treatment of cell proliferative diseases, such as cancer.
    Type: Application
    Filed: November 9, 2017
    Publication date: March 8, 2018
    Applicant: PFIZER INC.
    Inventors: Brian Patrick Chekal, Nathan D. Ide
  • SOLID FORMS OF A SELECTIVE CDK4/6 INHIBITOR
    Publication number: 20160002223
    Abstract: This invention relates to the crystalline free base of acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, formula (1) having improved properties, to pharmaceutical compositions and dosage forms comprising the free base, and to methods for making and using such compounds, compositions and dosage forms in the treatment of cell proliferative diseases, such as cancer.
    Type: Application
    Filed: February 8, 2014
    Publication date: January 7, 2016
    Applicant: PFIZER INC.
    Inventors: Brian Patrick Chekal, Nathan D. Ide